Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Fiserv
FI
|
$723M |
| 2 |
GSK
GSK
|
$660M |
| 3 |
RTX Corp
RTX
|
$628M |
| 4 |
Wells Fargo
WFC
|
$527M |
| 5 |
Cisco
CSCO
|
$370M |
Top Sells
| 1 |
FedEx
FDX
|
$997M |
| 2 |
TE Connectivity
TEL
|
$880M |
| 3 |
Bank of America
BAC
|
$603M |
| 4 |
AstraZeneca
AZN
|
$575M |
| 5 |
Charles Schwab
SCHW
|
$564M |
Sector Composition
| 1 | Financials | 27.05% |
| 2 | Technology | 18.36% |
| 3 | Communication Services | 14.15% |
| 4 | Healthcare | 14.14% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
PayPal
PYPL
$65.7B
| $8.54M | 0.01% |
36,450
-2,200
| -6% | -$515K |
|
|
MXIM
102
DELISTED
Maxim Integrated Products
MXIM
| $7.56M | 0.01% |
85,258
-14,392
| -14% | -$1.28M |
|
103
Caterpillar
CAT
$195B
| $7.45M | 0.01% |
40,940
-511
| -1% | -$93K |
|
104
GE Aerospace
GE
$289B
| $7.34M | 0.01% |
679,183
+309,700
| +84% | +$3.34M |
|
105
Pfizer
PFE
$141B
| $7.27M | 0.01% |
197,406
-17,438
| -8% | -$642K |
|
106
IBM
IBM
$223B
| $6.61M | 0.01% |
52,510
-2,221
| -4% | -$280K |
|
107
Corning
GLW
$58.3B
| $6.19M | ﹤0.01% |
172,052
-9,600
| -5% | -$346K |
|
108
Apple
AAPL
$3.39T
| $5.46M | ﹤0.01% |
41,156
-4,000
| -9% | -$531K |
|
109
Vulcan Materials
VMC
$38.4B
| $5.3M | ﹤0.01% |
35,700
-3,500
| -9% | -$519K |
|
110
Boston Scientific
BSX
$157B
| $4.78M | ﹤0.01% |
132,990
-5,000
| -4% | -$180K |
|
111
Exxon Mobil
XOM
$487B
| $4.64M | ﹤0.01% |
112,501
-2,500
| -2% | -$103K |
|
112
Deere & Co
DE
$130B
| $4.17M | ﹤0.01% |
15,479
-1,050
| -6% | -$283K |
|
113
Danaher
DHR
$144B
| $4.15M | ﹤0.01% |
18,667
-3,275
| -15% | -$728K |
|
114
Amgen
AMGN
$155B
| $4.11M | ﹤0.01% |
17,857
-1,100
| -6% | -$253K |
|
115
Johnson & Johnson
JNJ
$429B
| $4.1M | ﹤0.01% |
26,055
-240
| -0.9% | -$37.8K |
|
116
Synopsys
SNPS
$110B
| $3.97M | ﹤0.01% |
15,330
| – | – |
|
117
US Bancorp
USB
$74.9B
| $3.84M | ﹤0.01% |
82,500
-7,800
| -9% | -$363K |
|
118
DuPont de Nemours
DD
$31.5B
| $3.33M | ﹤0.01% |
46,825
-1,173
| -2% | -$83.4K |
|
119
AT&T
T
$209B
| $3.01M | ﹤0.01% |
104,710
-7,936
| -7% | -$228K |
|
120
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.97M | ﹤0.01% |
12,820
| – | – |
|
121
Unilever
UL
$156B
| $2.94M | ﹤0.01% |
48,738
+44,238
| +983% | +$2.67M |
|
122
McDonald's
MCD
$224B
| $2.93M | ﹤0.01% |
13,675
-50
| -0.4% | -$10.7K |
|
|
RDS.A
123
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.88M | ﹤0.01% |
82,031
-17,683
| -18% | -$621K |
|
124
Diageo
DEO
$61.4B
| $2.67M | ﹤0.01% |
16,811
| – | – |
|
125
NetApp
NTAP
$22.7B
| $2.67M | ﹤0.01% |
40,300
-100
| -0.2% | -$6.62K |
|